Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 16, No 3 (2023) Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region Abstract  similar documents
A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin
"... Region (MR). Material and methods. Clinical and economic analysis of combined standard therapy ..."
 
Vol 16, No 1 (2023) Principles of medical care standards development based on clinical guidelines Abstract  similar documents
Yu. A. Ledovskikh, S. N. Tishkina, G. I. Pirova, E. V. Semakova, V. V. Omelyanovskiy
"... the changing requirements for the development of medical care standards and the current standard form ..."
 
Vol 16, No 4 (2023) Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation Abstract  similar documents
M. V. Zhuravleva, K. A. Kokushkin, E. A. Luchinin, E. V. Luchinina, T. R. Kameneva, E. V. Kuznetsova, V. S. Krysanova, E. V. Makarova, L. G. Zhukova
"... ” regimen, considering possible subsequent adjuvant therapy with trastuzumab emtansine or trastuzumab within ..."
 
Vol 15, No 4 (2022) Possibilities of physical therapy and electrophysical modalities in the complex therapy of pneumonia Abstract  similar documents
D. I. Korabelnikov, V. V. Grigoryev, О. V. Efimova
"... the effectiveness of pneumonia therapy is the widespread introduction of physical therapy (PT) and electrophysical ..."
 
Vol 16, No 1 (2023) Efficiency of Levilimab in patients with moderate and severe COVID-19 Abstract  similar documents
Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A.  S. Kolbin, M. V. Livshits, T.  A. Usmanova, A. M. Fakhrutdinova, Yu. S.  Konstantinova, A. P. Gubanov
"... (6% in the Levilimab group and 10% in the standard therapy group; odds ratio (OR) 1.71; 95 ..."
 
Vol 15, No 4 (2022) Medical rehabilitation of patients with menopausal syndrome and surgical menopause: contribution of magnesium deficiency correction Abstract  similar documents
D. V. Blinov, А. G. Solopova, Е. Е. Achkasov, G. К. Bykovshchenko, D. А. Petrenko
"... cancer, is a characteristic trend of the 21st century. Part of them receive menopausal hormone therapy ..."
 
Vol 16, No 2 (2023) Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic Abstract  similar documents
Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham
"... funding in the Syrian Arab Republic (SAR), pharmacoeconomic study of antiretroviral therapy (ART) regimens ..."
 
Vol 16, No 3 (2023) Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia Abstract  similar documents
A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva
"... (CAP) include the empirical prescription of antibiotic therapy (ABT) – beta-lactams, fluoroquinolones ..."
 
Vol 16, No 3 (2023) Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study Abstract  similar documents
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina
"... system: the costs of drug therapy, detecting and relieving adverse events, palliative care. A Markov ..."
 
Vol 16, No 3 (2023) An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis Abstract  similar documents
M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova
"... years). In the therapy group (n=17), patients received Laennec® HPH (4 ml intravenous drip infusion ..."
 
Vol 16, No 4 (2023) Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C Abstract  similar documents
I. A. Narkevich, E. A. Tsitlionok
"... Objective: to analyse the consumption pattern of antiviral therapy (AVT) for chronic hepatitis C ..."
 
Vol 16, No 3 (2023) Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy Abstract  similar documents
S. K. Zyryanov, I. N. Dyakov
"... provided with PD-1/ PD-L1 inhibitors in the second and third lines of therapy with atezolizumab ..."
 
Vol 16, No 2 (2023) Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 Abstract  similar documents
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova
"... ) in adults were published that did not contain interferon drug therapy regimens. Current therapy of chronic ..."
 
1 - 13 of 13 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)